Profiling of central metabolism in human cancer cells by two-dimensional NMR, GC-MS analysis, and isotopomer modeling

Metabolomics

Volumn 4, Issue 1, 2008, Pages 13-29

  Yang, Chen ^a   Richardson, Adam D ^a   Osterman, Andrei ^a   Smith, Jeffrey W ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

13C labeling; GC MS; Isotopomer model; Metabolome; NMR

Indexed keywords

EID: 38949185267     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-007-0094-y     Document Type: Article

References (57)

1. Anderson, M. S., & Raetz, C. R. (1987). Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine. Journal of Biological Chemistry, 262(11), 5159-5169.
2. Baron, A., Migita, T., Tang, D., & Loda, M. (2004). Fatty acid synthase: A metabolic oncogene in prostate cancer? Journal of Cellular Biochemistry, 91(1), 47-53.
3. Boren, J., Cascante, M., Marin, S., Comin-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W. N., & Boros, L. G. (2001). Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. Journal of Biological Chemistry, 276(41), 37747-37753.
4. Boren, J., Lee, W. N., Bassilian, S., Centelles, J. J., Lim, S., Ahmed, S., Boros, L. G., & Cascante, M. (2003). The stable isotope-based dynamic metabolic profile of butyrate-induced HT29 cell differentiation. Journal of Biological Chemistry, 278(31), 28395-28402.
5. Boros, L. G., Cascante, M., & Lee, W. N. (2002). Metabolic profiling of cell growth and death in cancer: Applications in drug discovery. Drug Discovery Today, 7(6), 364-372.
6. Bristow, R. G., Hardy, P. A., & Hill, R. P. (1990). Comparison between in vitro radiosensitivity and in vivo radioresponse of murine tumor cell lines. I: Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels. International Journal for Radiation Oncology and Biological Physics, 18(1), 133-145.
7. 13C NMR isotopomer analysis of anaplerotic pathways in INS-1 cells. Journal of Biological Chemistry, 279(43), 44370-44375.
8. Dauner, M., Bailey, J. E., & Sauer, U. (2001). Metabolic flux analysis with a comprehensive isotopomer model in Bacillus subtilis. Biotechnology and Bioengineering, 76(2), 144-156.
9. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995). NMRPipe: A multidimensional spectral processing system based on UNIX pipes. Journal of Biomolecular NMR, 6 (3), 277-293.
10. Eisenreich, W., Schwarzkopf, B., & Bacher, A. (1991). Biosynthesis of nucleotides, flavins, and deazaflavins in Methanobacterium thermoautotrophicum. Journal of Biological Chemistry, 266(15), 9622-9631.
11. 13C mass isotopomer distribution analysis of intermediates. Journal of Biological Chemistry, 270(17), 10037-10042.
12. Fischer, C. P., Bode, B. P., & Souba, W. W. (1998). Adaptive alterations in cellular metabolism with malignant transformation. Annals of Surgery, 227(5), 627-634; discussion 634-636.
13. Fischer, E., & Sauer, U. (2003). Metabolic flux profiling of Escherichia coli mutants in central carbon metabolism using GC-MS. European Journal of Biochemistry, 270(5), 880-891.
14. Gribbestad, I. S., Petersen, S. B., Fjosne, H. E., Kvinnsland, S., & Krane, J. (1994). 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR in Biomedicine, 7(4), 181-194.
15. Gribbestad, I. S., Sitter, B., Lundgren, S., Krane, J., & Axelson, D. (1999). Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Research, 19(3A), 1737-1746.
16. Griffin, J. L., & Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nature Reviews Cancer, 4(7), 551-561.
17. Griffith, O. W., & Meister, A. (1985). Origin and turnover of mitochondrial glutathione. Proceedings of the National Academy of Sciences of the USA, 82(14), 4668-4672.
18. Griffiths, J. R., McSheehy, P. M., Robinson, S. P., Troy, H., Chung, Y. L., Leek, R. D., Williams, K. J., Stratford, I. J., Harris, A. L., & Stubbs, M. (2002). Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): Evidence of an anabolic role for the HIF-1 pathway. Cancer Research, 62(3), 688-695.
19. Helmlinger, G., Sckell, A., Dellian, M., Forbes, N. S., & Jain, R. K. (2002). Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clinical Cancer Research, 8(4), 1284-1291.
20. Hosking, L. K., Whelan, R. D., Shellard, S. A., Bedford, P., & Hill, B. T. (1990). An evaluation of the role of glutathione and its associated enzymes in the expression of differential sensitivities to antitumour agents shown by a range of human tumour cell lines. Biochemical Pharmacology, 40(8), 1833-1842.
21. Hua, Q., Yang, C., Baba, T., Mori, H., & Shimizu, K. (2003). Responses of the central metabolism in Escherichia coli to phosphoglucose isomerase and glucose-6-phosphate dehydrogenase knockouts. Journal of Bacteriology, 185(24), 7053-7067.
22. 13C isotopomer model for estimation of anaplerotic substrate oxidation via acetyl-CoA. American Journal of Physiology, 271(4 Pt 1), E788-E799.
23. Katz-Brull, R., Seger, D., Rivenson-Segal, D., Rushkin, E., & Degani, H. (2002). Metabolic markers of breast cancer: Enhanced choline metabolism and reduced choline-ether-phospholipid synthesis. Cancer Research, 62(7), 1966-1970.
24. Knowles, L. M., Axelrod, F., Browne, C. D., & Smith, J. W. (2004). A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2. Journal of Biological Chemistry, 279(29), 30540-30545.
25. Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004). Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Research, 64(6), 2070-2075.
26. Kuhajda, F. P. (2000). Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology. Nutrition, 16(3), 202-208.
27. 13C]glucose metabolites. Journal of Biological Chemistry, 269 (44), 27198-27208.
28. Lee, F. Y., Siemann, D. W., & Sutherland, R. M. (1989). Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer - a possible indicator of chemosensitivity. British Journal of Cancer, 60(3), 291-298.
29. Lee, W. N., Bassilian, S., Guo, Z., Schoeller, D., Edmond, J., Bergner, E. A., & Byerley, L. O. (1994). Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis. American Journal of Physiology, 266(3 Pt 1), E372-E383.
30. 1H NMR spectroscopy in vivo, ex vivo, and in vitro. Journal of Biological Chemistry, 278(46), 45915-45923.
31. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proceedings of the National Academy of Sciences of the USA, 99(5), 2708-2713.
32. Maharjan, R. P., & Ferenci, T. (2003). Global metabolite analysis: the influence of extraction methodology on metabolome profiles of Escherichia coli. Analytical Biochemistry, 313(1), 145-154.
33. 13C NMR spectroscopy. Journal of Biological Chemistry, 263(15), 6964-6971.
34. Meister, A. (1991). Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacology & Therapeutics, 51(2), 155-194.
35. Miller, F. R. (2000). Xenograft models of premalignant breast disease. Journal of Mammary Gland Biology and Neoplasia, 5(4), 379-391.
36. Moreno, A., Rey, M., Montane, J. M., Alonso, J., & Arus, C. (1993). 1H NMR spectroscopy of colon tumors and normal mucosal biopsies; elevated taurine levels and reduced polyethyleneglycol absorption in tumors may have diagnostic significance. NMR in Biomedicine, 6(2), 111-118.
37. Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002). Metabonomics: A platform for studying drug toxicity and gene function. Nature Reviews Drug Discovery, 1(2), 153-161.
38. O'Donnell, N. (2002). Intracellular glycosylation and development. Biochimica et Biophysica Acta, 1573(3), 336-345.
39. Pal, K., Sharma, U., Gupta, D. K., Pratap, A., & Jagannathan, N. R. (2005). Metabolite profile of cerebrospinal fluid in patients with spina bifida: A proton magnetic resonance spectroscopy study. Spine, 30(3), E68-E72.
40. Patel, A. B., Srivastava, S., Phadke, R. S., & Govil, G. (1999). Identification of low-molecular-weight compounds in goat epididymis using multinuclear nuclear magnetic resonance. Analytical Biochemistry, 266(2), 205-215.
41. 13C]glucose incubation. European Journal of Biochemistry, 217 (1), 457-468.
42. 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites. NMR Biomed, 4(2), 59-63.
43. +-dependent malic enzyme activity and malate-dependent pyruvate formation are progression-linked in Morris hepatomas. Journal of Biological Chemistry, 255(9), 3844-3848.
44. Schmidt, K., Nielsen, J., & Villadsen, J. (1999). Quantitative analysis of metabolic fluxes in Escherichia coli, using two-dimensional NMR spectroscopy and complete isotopomer models. Journal of Biotechnology, 71(1-3), 175-189.
45. 13C NMR study. NMR in Biomedicine, 16(4), 213-223.
46. 1H magnetic resonance spectroscopy: A pilot study. Magnetic Resonance Imaging, 22(5), 697-706.
47. 31P-magnetic resonance spectroscopy study. Cancer Research, 61(20), 7536-7543.
48. 13 C-labeling of proteinogenic amino acids. An efficient analytical tool to investigate intermediary metabolism. European Journal of Biochemistry, 232(2), 433-448.
49. 13C-labeling. Journal of Biomolecular NMR, 2(4), 323-334.
50. Timbrell, J. A., Seabra, V., & Waterfield, C. J. (1995). The in vivo and in vitro protective properties of taurine. General Pharmacology, 26(3), 453-462.
51. 1H magnetic resonance spectroscopy. Metabolomics, 1(4), 293-303.
52. 13C-labeling. Metabolic Engineering, 3(2), 151-162.
53. Vercoutere, B., Durozard, D., Baverel, G., & Martin, G. (2004). Complexity of glutamine metabolism in kidney tubules from fed and fasted rats. Biochemistry Journal, 378(Pt 2), 485-495.
54. Wice, B. M., Trugnan, G., Pinto, M., Rousset, M., Chevalier, G., Dussaulx, E., Lacroix, B., & Zweibaum, A. (1985). The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate. Journal of Biological Chemistry, 260(1), 139-146.
55. Wiechert, W. (1997). Bidirectional reaction stpes in metabolic networks: I. Modeling and simulation of carbon isotope labeling experiments. Biotechnology and Bioengineering, 55, 101-117.
56. Wiechert, W., Mollney, M., Isermann, N., Wurzel, M., & de Graaf, A. A. (1999). Bidirectional reaction steps in metabolic networks: III. Explicit solution and analysis of isotopomer labeling systems. Biotechnology and Bioengineering, 66(2), 69-85.
57. Wittmann, C., & Heinzle, E. (1999). Mass spectrometry for metabolic flux analysis. Biotechnology and Bioengineering, 62(6), 739-750.